These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20232019)

  • 1. [Multidrug resistant Acinetobacter baumanii:clinical update and new highlights].
    Torres HA; Vázquez EG; Yagüe G; Gómez JG
    Rev Esp Quimioter; 2010 Mar; 23(1):12-9. PubMed ID: 20232019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic analysis of Acinetobacter bloodstream infection isolates in a Turkish university hospital.
    Alp E; Esel D; Yildiz O; Voss A; Melchers W; Doganay M
    Scand J Infect Dis; 2006; 38(5):335-40. PubMed ID: 16709534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acinetobacter baumannii: an emerging multidrug-resistant threat.
    Gootz TD; Marra A
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):309-25. PubMed ID: 18588496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.
    Baran G; Erbay A; Bodur H; Ongürü P; Akinci E; Balaban N; Cevik MA
    Int J Infect Dis; 2008 Jan; 12(1):16-21. PubMed ID: 17513154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Acinetobacter infections.
    Michalopoulos A; Falagas ME
    Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia.
    Metan G; Sariguzel F; Sumerkan B
    Eur J Intern Med; 2009 Sep; 20(5):540-4. PubMed ID: 19712862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand.
    Anunnatsiri S; Tonsawan P
    Southeast Asian J Trop Med Public Health; 2011 May; 42(3):693-703. PubMed ID: 21706949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
    J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii infections among hospitalized patients: risk factors and outcomes.
    Shanthi M; Sekar U
    J Assoc Physicians India; 2009 Sep; 57():636, 638-40, 645. PubMed ID: 20214000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing strategy of multidrug-resistant Acinetobacter baumanii susceptible only to colistin in cardiac surgical intensive care units.
    Mastoraki A; Douka E; Kriaras I; Stravopodis G; Saroglou G; Geroulanos S
    Eur J Cardiothorac Surg; 2008 Jun; 33(6):1086-90. PubMed ID: 18339553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic options for Acinetobacter baumannii infections.
    Vila J; Pachón J
    Expert Opin Pharmacother; 2008 Mar; 9(4):587-99. PubMed ID: 18312160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multidrug resistant Acinetobacter baumannii].
    Nemec A
    Klin Mikrobiol Infekc Lek; 2008 Oct; 14(5):162-7. PubMed ID: 19051163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii.
    Sheng WH; Liao CH; Lauderdale TL; Ko WC; Chen YS; Liu JW; Lau YJ; Wang LH; Liu KS; Tsai TY; Lin SY; Hsu MS; Hsu LY; Chang SC
    Int J Infect Dis; 2010 Sep; 14(9):e764-9. PubMed ID: 20646946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex.
    Tacconelli E; Cataldo MA; De Pascale G; Manno D; Spanu T; Cambieri A; Antonelli M; Sanguinetti M; Fadda G; Cauda R
    J Antimicrob Chemother; 2008 Nov; 62(5):1130-7. PubMed ID: 18635519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impacts of a single clone (sequence type 92) of multidrug-resistant Acinetobacter baumannii in intensive care units.
    Heo ST; Oh WS; Kim SJ; Bae IG; Ko KS; Lee JC
    Microb Drug Resist; 2011 Dec; 17(4):559-62. PubMed ID: 21830907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outbreak of resistant Acinetobacter baumannii- measures and proposal for prevention and control.
    Romanelli RM; Jesus LA; Clemente WT; Lima SS; Rezende EM; Coutinho RL; Moreira RL; Neves FA; Brás Nde J
    Braz J Infect Dis; 2009 Oct; 13(5):341-7. PubMed ID: 20428632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unit.
    Holloway KP; Rouphael NG; Wells JB; King MD; Blumberg HM
    Ann Pharmacother; 2006 Nov; 40(11):1939-45. PubMed ID: 17018688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection.
    Jamulitrat S; Arunpan P; Phainuphong P
    J Med Assoc Thai; 2009 Mar; 92(3):413-9. PubMed ID: 19301737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multidrug-resistant Acinetobacter baumannii infection in respiratory intensive care unit].
    Bacakoğlu F; Korkmaz Ekren P; Taşbakan MS; Başarik B; Pullukçu H; Aydemir S; Gürgün A; Başoğlu OK
    Mikrobiyol Bul; 2009 Oct; 43(4):575-85. PubMed ID: 20084910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of patients infected with carbapenem-resistant Acinetobacter baumannii treated with single or combination antibiotic therapy.
    Santimaleeworagun W; Wongpoowarak P; Chayakul P; Pattharachayakul S; Tansakul P; Garey KW
    J Med Assoc Thai; 2011 Jul; 94(7):863-70. PubMed ID: 21774295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.